MRNA - Moderna, Inc.
57.8
7.970 13.789%
Share volume: 22,334,586
Last Updated: 03-04-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.44%
PREVIOUS CLOSE
CHG
CHG%
$49.83
7.97
0.16%
Summary score
13%
Profitability
0%
Dept financing
9%
Liquidity
45%
Performance
20%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2014 - 31-Dec-2018
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-8.07%
Return on assets
-5.81%
Return on sales
0%
Return on invested capital
-55.66%
Total debt ratio
30.69%
Debt ratio change over timeo
0%
Current Ratio
5.7%
Quick Ratio
0%
Cash Position Ratio
1.52%
Short-term ratios 31-Dec-2017 - 31-Dec-2018
The data are presented for the financials results of the quarters of the last year.
Return on equity
-8.79%
Return on assets
-6.78%
Return on sales
0%
Return on invested capital
-64.62%
Total debt ratio
24.86%
Debt ratio change over timeo
0%
Current Ratio
6.51%
Quick Ratio
0%
Cash Position Ratio
1.93%
Last quarter ratios 31-Dec-2018
The data are presented for the financials results of the last quarter.
Return on equity
-9.42%
Return on assets
-7.8%
Return on sales
0%
Return on invested capital
-81.72%
Total debt ratio
22.01%
Debt ratio change over time
0%
Current Ratio
7.02%
Quick Ratio
0%
Cash Position Ratio
2.96%
Performance ratios (change over 4 years) 31-Dec-2014 - 31-Dec-2018
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
0%
Return on assets
0%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
0%
Debt ratio change over time
0%
Current Ratio
0%
Quick Ratio
0%
Cash Position Ratio
0%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | MRNA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -8.07% | 7.28% | 9.32% | 7.23% |
| Return on assets | -5.81% | 3.37% | 5.52% | 5.41% |
| Return on sales | 0% | 43.45% | 49.58% | 43.11% |
| Return on invested capital | -55.66% | 7.6% | 8.14% | 7.34% |
| Profitability | 0% | 80% | 100% | 88% |
| Total debt ratio | 30.69% | 67.42% | 66.51% | 46.84% |
| Debt ratio change over time | 0% | 0% | 3.92% | 4.65% |
| Dept financing | 11% | 25% | 46% | 42% |
| Current Ratio | 6.51% | 3.29% | 3.17% | 2.66% |
| Quick Ratio | 0% | 3.03% | 3.09% | 2.38% |
| Cash Position Ratio | 1.93% | 0.83% | 2.59% | 1.34% |
| Liquididy | 48% | 52% | 54% | 37% |
| Short-term ratios | MRNA | AMGN | GILD | BIIB |
|---|---|---|---|---|
| Return on equity | -8.79% | 14.64% | 6.26% | 8.29% |
| Return on assets | -6.78% | 3.79% | 3.16% | 5.94% |
| Return on sales | 0% | 43.56% | 37.32% | 44.68% |
| Return on invested capital | -64.62% | 11.94% | 6.39% | 8.23% |
| Profitability | 0% | 90% | 58% | 81% |
| Total debt ratio | 24.86% | 78.97% | 66.55% | 47.35% |
| Debt ratio change over time | 0% | 0% | 3.92% | 4.65% |
| Dept financing | 8% | 25% | 42% | 40% |
| Current Ratio | 6.51% | 3.29% | 3.17% | 2.66% |
| Quick Ratio | 0% | 3.03% | 3.09% | 2.38% |
| Cash Position Ratio | 1.93% | 0.83% | 2.59% | 1.34% |
| Liquididy | 44% | 45% | 62% | 42% |